Anti-oxidative neuroprotection by estrogens in mouse cortical cultures

Journal of Korean Medical Science

Volumn 15, Issue 3, 2000, Pages 327-336

  Bae, Yeong Hee ^a   Hwang, Jee Yeon ^a   Kim, Yang Hee ^a   Koh, Jae Young ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Alzheimer Disease; Antioxidants; Estrogens; Neuroprotective Agents

Indexed keywords

6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); ANTIOXIDANT; CHELATING AGENT; CHROMAN DERIVATIVE; ESTRADIOL; ESTROGEN; ESTRONE; ETHYLENEDIAMINE DERIVATIVE; FERRIC CHLORIDE; FERRIC ION; LACTATE DEHYDROGENASE; N METHYLASPARTIC ACID; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; N,N,N',N'-TETRAKIS(2-PYRIDYLMETHYL)ETHYLENEDIAMINE; PEPTIDE FRAGMENT; STAUROSPORINE; TROLOX C;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CORTI ORGAN; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; NERVE CELL;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; CHELATING AGENTS; CHROMANS; ESTRADIOL; ESTROGENS; ESTRONE; ETHYLENEDIAMINES; EXCITATORY AMINO ACID AGONISTS; FERRIC COMPOUNDS; L-LACTATE DEHYDROGENASE; MICE; N-METHYLASPARTATE; NEURONS; ORGAN OF CORTI; PEPTIDE FRAGMENTS; STAUROSPORINE;

EID: 0034199379     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2000.15.3.327     Document Type: Article

References (41)

1. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease. Am J Epidemiol 1994; 140: 256-61.
2. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn NM, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and controls. Arch Neurol 1994; 51: 896-900.
3. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E. Postmenopausal estrogen replacement therapy and risk of AD. Neurology 1999; 52: 965-70.
4. Tang NIX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-32.
5. Birge SJ. The role of estrogen in the treatment and prevention of dementia. Am J Med 1997; 103(suppl 3A): 19-25.
6. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986; 11: 337-45.
7. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 1998; 4: 447-51.
8. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 1994; 269: 13065-8.
9. Green PS, Gridley KE, Simpkins JW. Estradiol protects β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neuroscience Lett 1996; 218: 165-8.
10. Behl C, Widmann M, Trapp T, Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995; 216: 473-82.
11. Mook-Jung I, Joo I, Sohn S, Kwon HJ, Huh K, Jung MW. Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension on B103 cells. Neuroscience Lett 1997; 235: 101-4.
12. Goodman Y, Bruce AJ, Cheng BB, Mattson MP. Estrogens attenuate and corticosterone exacervates excitotoxicity, oxidative injury, and amyloid b-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66: 1836-44.
13. Regan RF, Guo Y. Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res 1997; 764: 133-40.
14. Singer CA, Rogers KL, Strickland TM, Dorsa AM. Estrogen protects primary cotical neurons from glutamate toxicity. Neuroscience Lett 1996; 212: 13-6.
15. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 17 beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 1997; 761: 338-41.
16. Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea B. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 1995; 30: 141-6.
17. Vedder H, Anthes N, Stumm G, Wurz C, Behl C, Krieg JC. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 1999; 72: 2531-8.
18. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997; 51: 535-41.
19. Mattson MP, Guo ZH, Geiger JD. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem 1999; 73: 532-7.
20. Mattson MP, Pedersen WA. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease. Int J Dev Neurosci 1998; 16: 737-53.
21. Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured conical neurons to excitotoxic damage. Brain Res 1990; 533: 315-20.
22. Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptor-independent neuroprotection by estratriens: a novel interaction with glutathione. Neuroscience 1998; 84: 7-10.
23. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307.
24. Ahn YH, Kim YH, Hong SH, Koh JY. Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Exp Neurol 1998; 154: 47-56.
25. Choi DW, Maulucci-Gedde MA, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci 1987; 7: 357-68.
26. Choi DW, Koh JY, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 1988; 8: 185-96.
27. Booher J, Sensenbrenner M. Growth and cultivation of dissociated neurons from embryonic chick, rat and human in flask cultures. Neurobiology 1972; 2: 97-105.
28. Koh JY, Choi DW. Quantitative determination of glutamate mediated cotical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 1987; 20: 83-90.
29. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 1979; 95: 351-8.
30. Greenlund LJS, Deckwerth TL, Johnson EM Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14: 303-15.
31. Galli G, Fratelli M. Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetyl-carnitine. Exp Cell Res 1993; 204: 54-60.
32. Rawson CL, Loo DT, Duimstra JR, Hedstrom OR, Schmidt EE, Barnes DW. Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. J Cell Biol 1991; 113: 671-80.
33. Martin DP, Schmidt RE, DiStefano PS, Lowry OH, Carter JG, Johnson EM Jr. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988; 106: 829-44.
34. Koh JY, Wie MB, Gwag BJ, Sensi SL, Canzoniero LM, Demaro J, Csernansky C, Choi DW. Staurosporine-induced neuronal apoptosis. Exp Neurol 1995; 135: 153-9.
35. Camins A, Gabriel C, Aguirre L, Sureda FX, Pubill D, Pallas M, Escubedo E, Camarasa J. U-83836E prevents kainic acid-induced neuronal damage. Arch Pharmacol 1998; 357: 413-8.
36. Zhou Y, Gopalakrishnan V, Richardson JS. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J Neurochem 1996; 67: 1419-25.
37. Purdie DM, Bain CJ, Siskind V, Russell P, Hacker NF, Ward BG, Quinn MA, Green AC. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer 1999; 81: 559-63.
38. Andren-Sandberg A, Hoem D, Backman PL. Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol 1999; 10 (suppl 4): 131-5.
39. Roach M III. Current status of androgen suppression and radiotherapy for patients with prostate cancer. J Steroid Biochem Mol Biol 1999; 69: 239-45.
40. Barinaga M. Stroke-damaged neurons may commit cellular suicide. Science 1998; 281: 1302-3.
41. Cotman CW, Su JH. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 1996; 6: 493-506.